Medical Bulletin 1/September/2022
Advertisement
Here are the top medical news for the day:
Addiction management may help treat heart infection in drug addicts
Addiction management may help treat heart infection in drug addicts Managing a potentially deadly heart infection is complex in people who inject drugs, including opioids, stimulants, and others, and requires a unique approach to care including consultation with an addiction specialist, according to a new American Heart Association Scientific Statement published in the Association's flagship journal Circulation.
Infective endocarditis is caused by bacteria that enter the bloodstream and settle in the heart lining, a heart valve or a blood vessel. In this new scientific statement, "Management of Infective Endocarditis in People Who Inject Drugs," the American Heart Association highlights the need for specialized care in people who inject drugs, a population that has not been addressed in detail in previous guidance from the Association.
Ref:
Et al,Daniel C. DeSimoneDOI: 10.1161/CIR.0000000000001090
Link between low physical function and future cardiovascular diseases in elderly
Among people older than age 65 who were assessed using a short physical function test, having lower physical function was independently associated with a greater risk of developing heart attack, heart failure and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
The Short Physical Performance Battery (SPPB) used in this study is considered a measure of physical function, which includes walking speed, leg strength and balance. This study examined physical function, which is different from physical fitness.
Ref:
Xiao Hu et al,Journal of the American Heart Association, DOI: 10.1161/JAHA.121.025780
Improving effects of protein-based COVID-19 vaccines
In a new study in ACS Infectious Diseases, researchers report a substance that boosted the immune response to an experimental COVID-19 shot in mice by 25 times, compared to injection with the vaccine alone. Researchers have found that molecules derived from α-galactosylceramide (αGC), a compound from marine sponges, can act as adjuvants by stimulating a small population of immune cells important for defending the body against viral infections.
The team made four analogs of αGC and added each to an experimental vaccine containing a piece of SARS-CoV-2's spike protein, which the virus uses to infect cells. The researchers gave mice three injections over 29 days and tracked their immune response out to 35 days. To measure the effects of the adjuvants, they looked at various aspects of immune function, including two ways the immune system eliminates pathogens: through antibodies, which are immune proteins that latch onto an invader, and T cells, which kill diseased cells.
Ref:
Rui Luo et al,A new iNKT-cell agonist-adjuvanted SARS-CoV-2 subunit vaccine elicits robust neutralizing antibody responses,ACS Infectious Diseases, DOI: 10.1021/acsinfecdis.2c00296
Rivers and canals may help boost your mood: Study
A recent study, carried out by King's College London, Nomad Projects and J & L Gibbons in partnership with the Canal & River Trust, shows that spending time by canals and rivers is linked to feeling happy and healthy.Researchers report that the combination of blue and green space with wildlife has a greater impact on wellbeing than spending time in an environment that is characterized by only green space.
The study found that visiting canals and rivers was associated with a greater improvement in mental wellbeing, and this relationship was still present when accounting for individual variation due to age, gender, education, ethnicity, and a diagnosis of a mental health condition. People also reported continued improvements in their mental wellbeing for up to 24 hours after the visit had taken place.
Ref:
Going with the flow: study shows canals help boost your mood,DOI: 10.1371/journal.pone.0271306
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.